http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11535123

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage e842
issn 1083-7159
1549-490X
issueIdentifier 5
pageRange e833-e842
publicationName The Oncologist
startingPage e833
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c04fd0c1eda847c5e722e761bd859dc8
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e8b9d0fe8ad178109bbf8839e2e59b33
bibliographicCitation Liu Y, Hu X, Jiang J, Yang L, Zhou S, Liu P, Li J, Wang Y, Hao X, Shi Y. A Prospective Study of Apatinib in Patients with Extensive-Stage Small Cell Lung Cancer After Failure of Two or More Lines of Chemotherapy. Oncologist. 2020 May;25(5):e833–42. PMID: 32250517; PMCID: PMC7216448.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e86012ae9cc5c9b6101e2c8578afb7be
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8ddf85cd918af406c5ac8909b73271f4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cb571e775701a79dea00423a01d6bed5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f749cfdca0d90dd1b6d4e4932dc98ecc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_47efe58cb03d902909c0e7512317fbd7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0999a7c8a54e4104882e4b82af6650e1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_33fcb06fc4f1bcd24f66a84c264d1a29
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2febd6dbabe0218f487bcba9f45e97af
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5bf9bd21453e535f82c55e5cac6538e3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_56ed83decb95973e3d319ba0fcc32434
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4080-1294
date 2020-04-06^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1634/theoncologist.2019-0391
https://pubmed.ncbi.nlm.nih.gov/PMC7216448
https://pubmed.ncbi.nlm.nih.gov/32250517
isPartOf https://portal.issn.org/resource/ISSN/1549-490X
https://portal.issn.org/resource/ISSN/1083-7159
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21392
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title A Prospective Study of Apatinib in Patients with Extensive-Stage Small Cell Lung Cancer After Failure of Two or More Lines of Chemotherapy
discusses http://id.nlm.nih.gov/mesh/M0018233
http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0356369
http://id.nlm.nih.gov/mesh/M0551682
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D008175Q000188
http://id.nlm.nih.gov/mesh/D000970Q000009
http://id.nlm.nih.gov/mesh/D055752Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D011725
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D011446
http://id.nlm.nih.gov/mesh/D042461
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11136
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8989
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID131750276
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11315474
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45139106
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cb58e6788fc9a69c674bb00f98bffc14

Showing number of triples: 1 to 53 of 53.